| Online-Ressource |
Verfasst von: | Hausen, Gerrit zur [VerfasserIn]  |
| Springfeld, Christoph [VerfasserIn]  |
| Härtel, Nicolai [VerfasserIn]  |
| Hofheinz, Ralf-Dieter [VerfasserIn]  |
Titel: | Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values |
Titelzusatz: | data from the German QoliXane pancreatic cancer registry |
Verf.angabe: | G. zur Hausen, O. Waidmann, M.A. Woerns, H.G. Hoeffkes, S. Doerfel, M.O. Zahn, A. Aldaoud, M. Stauch, C. Springfeld, N. Haertel, A. Reichart, T.O. Goetze, S. Schwarz, C. Pauligk, J. Roemmler-Zehrer, R.D. Hofheinz, S.-E. Al-Batran |
E-Jahr: | 2016 |
Jahr: | 11 October 2016 |
Fussnoten: | Gesehen am 15.11.2017 |
Titel Quelle: | Enthalten in: Annals of oncology |
Ort Quelle: | Amsterdam [u.a.] : Elsevier, 1990 |
Jahr Quelle: | 2016 |
Band/Heft Quelle: | 27(2016,Supplement 6) Artikel-Nummer 684P, 1 Seite |
ISSN Quelle: | 1569-8041 |
Abstract: | © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Hyperbilirubinaemia is a common disease effect in patients (pts) with metastatic pancreatic cancer (mPC). As clinical trials often exclude them, data on management of these pts are rare. In the framework of a German observational multicenter study (QoliXane), quality of life and therapy data are currently being collected in pts with mPC receiving a combination of nab-paclitaxel and gemcitabine. This is an interim analysis on hyperbilirubinaemia management.Methods: Pts were included to this analysis if they entered the trial with a bilirubin level ≥ 1.2 mg/dl and completed at least 2 cycles. Bilirubin levels were documented for up to 4 cycles and methods of hyperbilirubinaemia management have been assessed. A both descriptive and explorative analysis was performed using IBM SPSS V 23.Results:... |
DOI: | doi:10.1093/annonc/mdw371.76 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: http://dx.doi.org/10.1093/annonc/mdw371.76 |
| kostenfrei: Volltext: https://academic.oup.com/annonc/article/27/suppl_6/684P/2799431 |
| DOI: https://doi.org/10.1093/annonc/mdw371.76 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1565372972 |
Verknüpfungen: | → Zeitschrift |
Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values / Hausen, Gerrit zur [VerfasserIn]; 11 October 2016 (Online-Ressource)